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lostridial neurotoxins are bacterial endopepti-
dases that cleave the major SNARE proteins in
peripheral motorneurons. Here, we show that dis-
ruption of synaptic architecture by botulinum neurotoxin
C1 (BoNT/C) in central nervous system neurons activates
distinct neurodegenerative programs in the axo-dendritic
network and in the cell bodies. Neurites degenerate at an
early stage by an active caspase-independent fragmenta-
tion characterized by segregation of energy competent
mitochondria. Later, the cell body mitochondria release
C
 
cytochrome 
 
c
 
, which is followed by caspase activation,
apoptotic nuclear condensation, loss of membrane poten-
tial, and, ﬁnally, cell swelling and lysis. Recognition and
scavenging of dying processes by glia also precede the
removal of apoptotic cell bodies, in line with a temporal
and spatial segregation of different degenerative pro-
cesses. Our results suggest that, in response to wide-
spread synaptic damage, neurons ﬁrst dismantle their
connections and ﬁnally undergo apoptosis, when their
spatial relationships are lost.
 
Introduction
 
Synapse remodelling is a physiological process used to refine
neuronal circuits during development. Exuberant projections
and axonal branches that have been directed toward inappropriate
targets are usually removed by mechanisms, which seem to be
evolutionary conserved (Bagri et al., 2003; Watts et al., 2003).
Similar mechanisms are not confined to the developing brain,
but are still present in the adult nervous system where they
ensure structural plasticity of neurons in response to learning
and memory (Bailey and Kandel, 1993; Lichtman and Colman,
2000). Local self-destruction programs regulate this fine re-
finement of neuronal circuits, thereby enabling a selective
elimination of unused connections without affecting the re-
maining branches or the cell soma (Walsh and Lichtman,
2003). As often observed in nature, similar mechanisms seem
to be active also in some pathological conditions where selec-
tive degeneration of injured axons can occur in response to local
insults (Raff et al., 2002). Selective axonal degeneration in the
peripheral nervous system has received considerable attention
(Schaumburg et al., 1974; Coleman and Perry, 2002). Axotomy
of peripheral nerves results in the degeneration of the distal
portion of the axon by an active process termed Wallerian de-
generation (Waller, 1850; Gillingwater and Ribchester, 2001).
Alternatively, degeneration may begin in the distal axon ex-
tremities and progress backward to the soma by a “dying-back”
process, as observed in many peripheral nerve diseases (Raff et
al., 2002). The mechanisms leading to axonal degeneration and
the final demise of the cell body are largely unknown, although
there is compelling evidence that different execution systems
operate in the axons and in the cell bodies during Wallerian de-
generation (Finn et al., 2000; Raff et al., 2002). Interestingly,
local apoptotic-like mechanisms may be recruited to dispose of
synapses and dendritic spines, at least in in vitro models of injury
(Davies et al., 1987; Ivins et al., 1998; Mattson et al., 1998).
Growing evidence suggests that disruption of synapse in-
tegrity or function may be even more relevant than neuronal
loss in slow, central degenerative disorders such as Alzhei-
mer’s (AD), Huntington’s (HD), and Parkinson’s diseases.
Loss of synapses is proportionally greater than the loss of neu-
rons in AD patients (Davies et al., 1987), and a strong correla-
tion exists between cognitive decline and loss of presynaptic
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terminals (Hatanpaa et al., 1999; Sze et al., 1997). A marked
decrease in striatal volume, without changes in cell number,
has also been reported in mouse models of HD (Mangiarini et
al., 1996; Yamamoto et al., 2000). This suggests that the loss of
neurites and synaptic failure may determine the HD phenotype.
Interestingly, reduced synaptic connectivity without neuronal
loss is also a relevant feature of neuropsychiatric diseases such
as schizophrenia (McGlashan and Hoffman, 2000; Frankle et
al., 2003; Gasic and Nicotera, 2003).
Widespread, but selective, synaptic damage can be elic-
ited by using clostridial neurotoxins of the botulinum family.
Botulinum neurotoxins (BoNTs) act inside neuronal synapses
as metalloproteinases, which specifically cleave the major
SNARE proteins (Blasi et al., 1993b; Schiavo et al., 1992a,b).
In so doing, BoNTs block neurotransmitter release at the neu-
romuscular junction in vivo or in the cortical, hippocampal,
and cerebellar granule neurons in vitro (Osen-Sand et al., 1996;
Verderio et al., 1999; Foran et al., 2003).
Despite the accumulating evidence that the synapse, axon,
and soma may represent separate degenerative compartments,
it is still unclear whether synaptic damage may initiate neu-
ronal death and whether this involves spatially and temporally
distinct programs. To address these issues, we set up a model
of axonal degeneration driven by BoNT/C-mediated synaptic
damage in central neurons.
In cerebellar granule cells (CGCs), BoNT/C triggered two
neurodegenerative events that were distinct in space and time: (1)
an early neurite degeneration, which occurred independently of
trophic stimulation and the activation of death-signaling kinases,
and which did not involve the apoptosis-executing machinery
(caspases); and (2) a late apoptotic demise of the cell bodies,
which was prevented by kinase inhibition and involved cyto-
chrome 
 
c
 
 release and caspase activation. The compartmentaliza-
tion of the two degenerative events was emphasized by the selec-
tive recognition and removal of different regions in degenerating
neurons. These data suggest that widespread synaptic damage
caused by BoNT/C in central neurons can initiate different degen-
erative programs spatially and temporally that recapitulate many
relevant features found in human neurodegenerative disorders.
 
Results
 
Synaptic disarray by BoNT/C causes 
CGC apoptosis
 
Once internalized by neurons, BoNT/C selectively proteolyzes
syntaxin and SNAP-25, which are two of the major SNARE
proteins responsible for neurotransmitter release. To determine
whether BoNT/C was active, we examined the integrity of syn-
taxin and SNAP-25 in CGCs. 3 h after the addition of BoNT/C,
the intensity of the syntaxin band on Western blot decreased
progressively (Fig. 1 A). In agreement with recent findings
(Foran et al., 2003), only a small amount of the syntaxin cleav-
age product was detected on gels, which is presumably caused
by rapid degradation of the fragment. Also, SNAP-25 disap-
peared after treatment with the toxin, although with slower ki-
netics (Fig. 1 A). Thus, BoNT/C entered CGCs and acted as an
intracellular specific protease in synapses.
Next, we examined whether BoNT/C triggered death of
CGCs. Cell death was concentration dependent in a range be-
tween 5 and 60 ng/ml BoNT/C and had obvious apoptotic fea-
tures (Fig. 1 B). Nuclear condensation and fragmentation be-
gan only after 24 h, and became widespread by 36 h (Fig. 1, C
and D). At these times, the plasma membrane of neuronal so-
mata was still intact, as revealed by the retention of fluorescent
calcein within cells (not depicted). Cell death was dependent
Figure 1. BoNT/C induces apoptosis in CGCs. (A) Time course of syntaxin
and SNAP-25 cleavage analyzed by Western blot in CGC lysates. Cells
were exposed to 20ng/ml BoNT/C for the time indicated. Concentration–
response (B) and time course (C) of BoNT/C-induced cell death. In B, cell
death was evaluated 30 h after treatment with the toxin, whereas in C,
cells were exposed to 20 ng/ml BoNT/C in the absence or the presence
of cycloheximide (CHX; 2  M). Apoptosis is expressed as a percentage of
condensed nuclei in cultures stained by H-33342 (D). Shown are HMM
DNA fragmentation (E) and DNA laddering (F) in cultures exposed to 20
ng/ml BoNT/C for the indicated times. Data are means   SD for triplicate
determinations. Bar, 30  m. 
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on protein synthesis because it was completely prevented by
coexposure to cycloheximide (Fig. 1 C). High molecular mass
(HMM) DNA fragments were detected by field inversion gel
electrophoresis (FIGE) after 24 h (Fig. 1 E), whereas oligonu-
cleosomal DNA fragmentation was detected at much later time
points (e.g., 36–48 h after exposure to BoNT/C; Fig. 1 F).
Cytochrome 
 
c
 
 was released from mitochondria within the
cell body starting 24 h after exposure to BoNT/C, as shown by
the loss of punctuate cytochrome 
 
c
 
 fluorescent staining and the
appearance of a diffuse pattern within the cell soma and the nu-
clear region (Fig. 2 A). Caspase-3 was activated concomitantly,
as shown by the increased DEVD-cleaving activity (Fig. 2 B)
and by the formation of the 120-kD fragment of fodrin (Fig. 2 C).
The broad spectrum caspase inhibitors zVAD-fluoromethylke-
tone (fmk) and z-D-2,6-dichlorobenzoyloxymethylketone (cbk)
blocked DEVDase activity (Fig. 2 B) as well as fodrin cleavage
(Fig. 2 C). Accordingly, HMM and oligonucleosomal DNA frag-
mentation (Fig. 2, D and E, respectively), as well as the apoptotic
morphological changes (Fig. 2 A and C), were prevented upon
caspase inhibition. In contrast, z-VAD-fmk concentrations as
high as 100 
 
 
 
M did not affect mitochondrial cytochrome 
 
c
 
 release
(Fig. 2 A). Because, caspase-2 may not be effectively inhibited
by zVAD-fmk (Nicholson, 1999), we used the more selective
caspase-2 inhibitor zVDVAD-fmk (1 
 
 
 
M); zVDVAD-fmk re-
duced cell death only in part, suggesting, however, a possible
role for caspase-2 in cell body apoptosis (Fig. 2 C).
 
BoNT/C-induced neurodegeneration is 
not caused by a block of 
neurotransmitter release
 
CGC apoptosis might have been caused by BoNT/C-mediated
block of neurotransmitter release that resulted in deprivation of
essential cell stimulation/trophic support. To test this possibil-
ity, we first measured glutamate release stimulated by KCl in
BoNT/C-treated neurons. Neurotransmitter release was fully
blocked at toxin concentrations as low as 2.5 and 5 ng/ml.
However, BoNT/C triggered only little apoptosis at those con-
centrations (Fig. 3 A).
In a second set of experiments, CGCs were treated with
BoNT/A. Whereas BoNT/C cleaves both syntaxin and SNAP-
25, BoNT/A blocks neurotransmission by exclusively targeting
SNAP-25 (Blasi et al., 1993a). In fact, treatment with BoNT/A
caused an almost complete block of glutamate release. But,
BoNT/A did not trigger neurite degeneration or apoptosis even
up to 72 h (Fig. 3 B).
In adult neurons, physiological, glutamatergic stimulation
is required for maintenance of postsynaptic structures (McKin-
ney et al., 1999). Therefore, we exposed BoNT/C-treated neu-
rons to a mild glutamatergic stimulation using either AMPA
(0.1–10 
 
 
 
M) or glutamate (0.5–1 
 
 
 
M). Addition of either of
the two agonists at the time of BoNT/C addition or 12 h after
BoNT/C addition did not prevent apoptosis (Fig. 3 C). Never-
theless, neurons were still able to respond to glutamate stimula-
tion because glutamate (300 
 
 
 
M for 1 h) triggered excitotox-
icity in BoNT/C-treated cultures, which was prevented by
blocking the NMDA receptor with 2 
 
 
 
M MK801 (Fig. 3 D).
Together, these data show that loss of glutamatergic transmission
was not the cause of CGC degeneration and that postsynap-
tic structures (i.e., NMDA receptors) remained operative in
degenerating neurons.
 
Caspase-independent axo-dendritic 
degeneration precedes the apoptotic 
demise of neuronal bodies
 
Well before the onset of apoptosis and starting 8–12 h after ad-
dition of BoNT/C to CGCs, their dense axo-dendritic network
underwent a progressive degeneration. Neurites displayed en-
larged varicosities by 12 h (Fig. 4 A) and blebs in the form of
pearl chainlike structures appeared along neurites (Fig. 4 B).
Next, the axo-dendritic network underwent a widespread frag-
Figure 2. Apoptotic demise of the cell bodies is a caspase-dependent
process. (A) Cytochrome c release analyzed by confocal microscopy at
the level of the cell bodies in BoNT/C-treated CGCs. The release, denoted
by the diffuse staining, was not prevented by caspase inhibition (e.g., by
100  M zVAD-fmk). Cells were exposed to 20 ng/ml BoNT/C for 30 h.
Shown are the time course of caspase activation measured by enzymatic
assay (B) and fodrin cleavage (C) in CGC lysates exposed to 20 ng/ml
BoNT/C for the indicated times. Caspase inhibition by 100  M zVAD-fmk
prevented the increase in DEVD-afc cleaving activity (B), fodrin cleavage
and apoptosis (C), nuclear condensation (A), HMM DNA fragmentation
(D), and DNA laddering (E). The caspase-2 inhibitor zVDVAD-fmk (1  M)
partially protected from apoptosis. Bar, 10  m. 
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mentation. Notably, most of these fragmented neurites were
still enclosed by an intact plasma membrane, as suggested by
scanning electron microscopy (Fig. 4 B) and shown by their
ability to retain the vital dye calcein-AM (see Fig. 6 B).
The breakdown of the neuronal projections was not pre-
vented by z-VADfmk (Fig. 4 A) nor by zVDVAD-fmk (not
depicted). Despite caspase activity being irrelevant for the dis-
mantling of the neuronal network, proteolytic processing of
Figure 3. BoNT/C-induced apoptosis is independent of the block of
neurotransmitter release and is not prevented by glutamatergic stimulation.
(A) Dose–response of BoNT/C-induced block of neurotransmitter release
and correlation with apoptosis. Neurotransmitter release was triggered by
potassium depolarization in L-[G-
3H]glutamine–loaded cultures. (B) Com-
parison of the block of neurotransmitter release with apoptosis induced by
20 ng/ml BoNT/C and 2  g/ml BoNT/A. (C) CGCs were incubated with
20 ng/ml BoNT/C. After 12 h, 1  M AMPA or 0.5  M glutamate was
added, and, after 36 h, apoptosis was evaluated by H-33342 staining.
(D) CGCs were incubated with 20 ng/ml BoNT/C for 15 h. Then, they
were exposed to 300  M glutamate for 1 h, in the presence or in the
absence of 2  M MK801. Apoptosis was evaluated as a percentage of
condensed nuclei. Data are means   SD for triplicate determinations.
Figure 4. A caspase-independent axonal breakdown preceded the
apoptotic demise of the neuronal bodies. Appearance of the axo-dendritic
network in CGC cultures as shown by phase-contrast (A) and scanning
electron microscopy (B). The disassembly of the neuronal projections in the
presence of 20 ng/ml BoNT/C is noteworthy. The magnification used in B
allows the visualization of the only neuronal network. The p17 fragment of
caspase-3 was detected along the neuronal projections (C), as well as
within the cell bodies (D), by confocal microscopy. Note the absence of
staining when the antibody was preabsorbed with p20/p17 caspase-3.
Fluorescence images in C represent single focal planes acquired at the
level of the neurites. The arrow indicates the cell shown in D to illustrate
the presence of processed caspase-3 at the level of the cell body at 24 h.
The Western blot shows small amounts of caspase-3 processing in un-
treated neurons and 18 h after BoNT/C. Substantial activation is seen
after 32 h, when most neurons have undergone apoptosis (E). Note that
caspase inhibition by zVAD-fmk prevented nuclear condensation, but did
not prevent the dismantling of the neurites (A). Neurotrophic factors (100
ng/ml BDNF and 200 ng/ml IGF-1) and cAMP (1 mM) did not prevent ax-
onal degeneration (not depicted) and only BDNF partially protected from
apoptosis (E). Neurotrophic factors efficacy was monitored in parallel cul-
tures in which apoptosis was induced by K
  withdrawal. The percentage
of apoptosis was evaluated by scoring condensed, H33342-positive nuclei.
(F) Data are means   SD for triplicate determinations; *, P   0.005.
Bars: (A) 10  m; (B) 5  m; (C) 30  m; (D) 10  m. 
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caspase-3 was detected along the neurites when observed us-
ing an antibody specific for the large p17-20 fragment, which
forms an essential part of the activated enzyme (Fig. 4 C). No-
tably, a small amount of positive staining for processed
caspase-3 was detectable also in untreated neurons. To test
whether this was caused by aspecific binding, the antibody
was preadsorbed with processed caspase-3. As indicated in
Fig. 4 C, preadsorption neutralized the positive immunostain-
ing. Western blot analyses further confirmed the presence of
the p20/p17 fragment in untreated neurons (Fig. 4 E), thus
suggesting that a small amount of caspase-3 is normally pro-
cessed in CGC cultures. Substantial amounts of processed cas-
pase-3 were obviously detected in the cell bodies after 24 h
(Fig. 4, C and D), which is consistent with the increase in cas-
pase-3 activity (Fig. 2 B).
Because axo-dendritic degeneration caused by BoNT/C
involved mechanisms different from those causing cell body
apoptosis, we examined whether trophic factors known to be
neuroprotective would differently modulate the two degenera-
tive processes. We used growth factors (NGF, BDNF, and IGF-I)
and cAMP, which is part of the intracellular signaling path-
ways of several neurotrophins (D’Mello et al., 1993; Gaiddon
et al., 1996). NGF, IGF-I, and cAMP did not prevent apoptosis
of neuronal somata (Fig. 4 F) nor did they protect from neurite
fragmentation (not depicted). Similarly, replacement of the
original medium with medium from parallel, untreated cultures
did not protect from BoNT/C-induced neurodegeneration (un-
published data). Under the same conditions, 100 ng/ml BDNF
reduced apoptosis, but did not prevent neurite degeneration
(Fig. 4 F). These data further support the idea that two indepen-
dent mechanisms are responsible for axo-dendritic degenera-
tion and the demise of the cell bodies.
 
Neurites degenerate with cytoskeleton 
breakdown, but retain functional 
mitochondria
 
A general cytoskeletal disassembly occurred within the first 18 h
after the exposure to BoNT/C. The dense actin network, which
characterizes untreated cultures, became sparser, and the finest
projections were lost; consequently, there was an overall loss of
immunoreactivity (Fig. 5 A). Alterations of the microtubule net-
work were also apparent. Tubulin-positive enlarged varicosities,
or bleblike structures, became visible along the neurites 8 h after
treatment and were evident on the remaining neurites by 20 h
(Fig. 5, A and B). Interestingly, microtubule disassembly was
also accompanied by abnormal phosphorylation of the tau pro-
tein. Phosphorylation of one of the tau KXGS motifs was de-
tected 6 h after exposure to BoNT/C (Fig. 5 C) by using the
AT-8–like antibody 11b directed against the phosphorylated
epitope S202-205 that was detected in paired helical filaments-
tau (Biernat et al., 1992; Goedert et al., 1992). Using a different
set of antibodies (11b gave poor results with immunostaining),
we then examined the appearance and localization of phosphor-
ylated tau in degenerating neurons. After BoNT/C addition, the
pattern of tau distribution changed from a very diffuse to a
highly fluorescent, punctuate staining that was compatible with
a disorganization/aggregation of tau filaments (Fig. 5 D).
Thus, exposure to BoNT/C initiated an early cytoskeletal
disarray at the level of the neuronal projections. Cytoskeletal
alterations are intimately linked with changes in mitochondrial
distribution along neuronal projections (Ebneth et al., 1998;
Stamer et al., 2002). In BoNT/C-treated neurons, tetramethyl-
rhodamine ethyl ester
 
 (
 
TMRE)–loaded mitochondria along
neurites initially (6 h) displayed higher longitudinal motility
than those in control cells. By 12 h after the exposure to the
toxin, mitochondria had lost their elongated shape as a result of
shortening in a process morphologically analogous to mito-
Figure 5. Cytoskeletal disassembly and abnormal tau phosphorylation
accompanied the early degeneration of the neurites. (A) CGCs were ex-
posed to 20 ng/ml BoNT/C for the times indicated and immunostained
for actin and  III-tubulin. Confocal images were acquired from the same
field. The bulblike structures present at 8 h along the neurites are shown at
higher magnification in B (arrows). (C) The total amount of tau protein was
detected by the K9JA antibody, which recognizes tau independently of its
phosphorylation. In the same cell extracts, abnormal tau phosphorylation
was detected by using the S202/205 phosphospecific antibody 11b.
Neurons were exposed to 20 ng/ml BoNT/C for the indicated times.
(D) The pattern of tau distribution was determined by a different antibody
(Innogenetics) and changed in cells exposed to 20 ng/ml BoNT/C.
Images in A, B, and D are extended focus images derived by merging
50–60 focal planes acquired in the z dimension with a 63  oil 1.3 NA
apochromat objective. Bars, 20  m. 
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chondrial fission (Bossy-Wetzel et al., 2003). Mitochondria
progressively migrated into, and clumped in, discrete mem-
brane-enclosed regions. Interestingly, blebs along the neurites
always seemed to emerge around clustered mitochondria (un-
published data). Mitochondria in cell bodies clustered on one
side opposite to the nucleus (Fig. 6 A and Video 1, available at
http://www.jcb.org/cgi/content/full/jcb.200406126/DC1).
The membrane potential was remarkably retained in the
mitochondria present along degenerating axo-dendritic projec-
tions, and, even at late time points, TMRE-positive mitochondria
were still visible in most blebs and neurite fragments (Fig. 6 B).
Mitochondrial integrity and membrane potential were initially
retained also in the mitochondria clustering around the cell
nucleus. However, shortly before nuclear condensation, cyto-
chrome 
 
c
 
 was released from somatic mitochondria (Fig. 2 A) and
the TMRE staining dissipated (Fig. 6 A and Video 1). In this
case, the events occurred quite rapidly as shown in other cell
types undergoing apoptosis (Goldstein et al., 2000). Soon after
the loss of the mitochondrial membrane potential, cell bodies
first shrunk, and then swelled and lysed (Fig. 6 A and Video 1).
To further confirm that mitochondria in fragmenting neu-
rites retained structural integrity, we performed a double im-
munostaining for cytochrome 
 
c
 
 and the mitochondrial heat-
shocked protein 70 (mtHSP-70). Colocalization was quantified
using a point-spread function by using the ImarisColoc soft-
ware. As shown in Fig. 6 (C and D), even at late time points,
when the axo-dendritic network was severely compromised,
cytochrome 
 
c
 
 and HSP-70 stainings remained colocalized in
the fragmenting neurites. This corroborates the findings ob-
tained with TMRE, and further suggests that mitochondrial
functions are maintained long after the blebbing and the initial
disintegration of the neurites (Fig. 6 B).
 
Involvement of upstream kinases in 
BoNT/C-mediated neurodegeneration
 
Although neurite degeneration and the death of the cell body
are executed by different mechanisms, they may involve a
common initiating lethal signal and simply diverge down-
stream before mitochondrial dysfunction. Because a lack of
trophic and glutamatergic stimulation was excluded by the ex-
periments discussed above (compare Fig. 3 D), we targeted
some of the kinases implicated in neuronal death in both in
vitro and in vivo models (Harper and LoGrasso, 2001; Cruz
and Tsai, 2004; Jope and Johnson, 2004). These include the
MAPK, GSK-3, and Cdk-5 signaling pathways. Because of the
complexity of the MAPK cascade, we used CEP-1347, a syn-
thetic inhibitor, which does not act on JNK (c-Jun NH
 
2
 
-termi-
nal kinase)
 
 
 
directly, but inhibits the upstream MLK (mixed lin-
eage kinase). MLKs are upstream kinases that activate MAPKs
including JNK, ERK1/2, ERK5, and p38 (Wang et al., 2004).
The inhibition by 100 nM CEP-1347 delayed apoptosis in-
duced by BoNT/C (Fig. 7 A), but it did not protect against the
early degeneration of the neurites (Fig. 7 C). Similar results
were obtained also with the Cdk-5 inhibitor roscovitine (10
 
 
 
M) and with alsterpaullone (1 
 
 
 
M), which inhibits both
GSK3 and Cdk-5 (Fig. 7 B). A more selective GSK-3 inhibitor
(2 
 
 
 
M) had only a minor effect, although in combination with
roscovitine it prevented cell death. These results suggest that
both MAPKs and Cdk-5 have relevant roles in BoNT/C-trig-
gered apoptosis. However, because none of the kinase inhibi-
tors prevented neurite degeneration (Fig. 7 C), it is again appar-
ent that neurite loss and apoptosis were triggered by entirely
distinct signaling pathways.
Figure 6. Mitochondrial integrity is retained during the early axonal
degeneration, but it is lost in the late demise of the cell bodies. BoNT/C-
treated CGCs were loaded with 20 nM TMRE and imaged by confocal
microscopy (A and B). Time series imaging of mitochondria at the level of
the cell bodies (A, a–e; time [h] a: 30; b: 37, c: 42, d: 42.5, and e:
43.5; Video 1, available at http://www.jcb.org/cgi/content/full/
jcb.200406126/DC1). (B) CGC treated with 20 ng/ml BoNT/C for 18 h
were loaded with calcein-AM (green) and TMRE (red) and imaged by con-
focal microscopy. The bottom panels show the detail of the related insets.
Note the presence of TMRE-positive mitochondria, which is indicative of a
retained membrane potential in the degenerating neurites and the different
mitochondrial morphology/distribution in BoNT/C-treated neurons versus
control. (C and D) Analysis of cytochrome c release along the neurites in
BoNT/C-treated cultures. CGCs were immunostained for cytochrome c
and mtHSP-70. Confocal images were acquired from the same field (C)
and colocalization quantified by ImarisColoc software (D). Scattergrams
show the percentage of the green channel voxels (cytochrome c [cyt c])
that colocalize with the red channel ones (mtHSP-70). Bars: (A) 5  m;
(B) 10  m; (C) 15  m. 
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Recognition and phagocytosis of 
degenerating neurites precedes removal 
of apoptotic cell bodies
 
Finally, we reasoned that if different degeneration processes
regulate loss of neuronal processes and apoptosis, signals for
phagocytosis and scavenging should also differ in the two neu-
ronal compartments. Glial cells actively scavenge neuronal de-
bris or whole dying neurons (Bechmann and Nitsch, 1997a,b)
and few glial cells (usually 
 
 
 
5%) are present in CGC cultures.
After exposure to BoNT/C, we noticed that the degenerating
axo-dendritic network became less dense, and large areas in
culture dishes were devoid of any remnants of neuronal neu-
rites. Therefore, we monitored the progression of events in
BoNT/C-treated CGC cultures over 48 h. As the degeneration
and fragmentation of neuronal projections progressed, contam-
inant glial cells became highly mobile and began to probe
the neuronal network by scavenging fragmented neurites and
eventually cellular debris (Fig. 8 A and Videos 2 and 3, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200406126/DC1).
Most notably, scavenging was initially restricted to neuronal
projections and did not affect the somata until they became
clearly apoptotic. Therefore, we set out to determine whether a
selective appearance of surface recognition molecules in de-
generating neurites would trigger such selective phagocytosis.
Cultures were loaded with Alexa 633–conjugated annexinV to
recognize phosphatidylserine, which is one of the main signal-
ing molecules in phagocytosis. Degenerating neurites, but not
the cell bodies, displayed phosphatidylserine during the first
24 h (Fig. 8 B and Fig. S1). Somata undergoing apoptosis dis-
played phosphatidylserine later, and were then removed by res-
ident glial cells. These data show that both recognition signals
and phagocytosis occur by two temporally and spatially dis-
tinct steps.
 
Discussion
 
Clostridial neurotoxins have long been used as a selective ex-
perimental tool for dissecting the molecular basis of synaptic
transmission (Bagetta et al., 1990; Schiavo et al., 2000). Re-
cently, their use has been extended to the therapeutic treatment
Figure 7. Effect of kinases inhibitors on BoNT/C-induced degeneration of
the neurites and death of the cell bodies. Time course of BoNT/C-induced
cell death in the presence of the MLK inhibitor CEP1347 (100 nM; A),
GSK-3 inhibitor (2  M), alsterpaullone, ALS (1  M), and roscovitine,
(10  M; B). Apoptosis was evaluated as a percentage of condensed nuclei
stained by H-33342. (C) CGCs were exposed to 20 ng/ml BoNT/C and
different kinase inhibitors for 18 h and were loaded with calcein-AM before
being imaged by confocal microscopy. Bar, 30  m.
Figure 8. Selective phosphatidylserine exposure on degenerating neurites
preluded their clearance by glial cells. BoNT/C-treated CGCs were fol-
lowed for 48 h by conventional time-lapse microscopy (A; and Videos 2 and
3, available at http://www.jcb.org/cgi/content/full/jcb.200406126/DC1).
As neurites degenerated and fragmented, a glial cell inhabiting the layer
below the neuronal network became activated and begun clearing dam-
aged projections. At a later stage (36–48 h), when cell bodies suc-
cumbed to apoptosis, the glial cell scavenged cell corpses (Videos 2 and
3, respectively). Images in A are extracted from Video 2 at the following
times (h): a, 1; b, 23; c, 34; and d, 40. (B) BoNT/C-treated CGCs were
loaded with Alexa 633–conjugated Annexin V (red) and calcein-AM
(green) and imaged by time-lapse confocal microscopy (B and Fig. S1).
The image in B and the rotation in Fig. S1 are three-dimensional render-
ings from multiple z-stacked images collected at 12 (top) and 18 h (bottom).
The calcein stain is masked by the appearance of annexin positivity
along the surface of neurites. Image stacks were collected by laser
scanning microscopy and rendered using the Imaris software. Bars: (A)
25  m; (B) 10  m. 
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of various human disturbances caused by excessive neu-
rotransmitter release (Cordivari et al., 2004). Their specificity
of action at the synapse is caused by the selective Zn
 
2
 
 
 
 en-
dopeptidase activity, which each serotype exerts against one
of the three major SNARE proteins, syntaxin, SNAP-25, and
VAMP/synaptobrevin. Among those three proteins, syntaxin
is the only one being targeted by a single toxin serotype,
BoNT/C (Schiavo et al., 1995). In mouse neurons, the cleav-
age is selective for syntaxin 1, which is localized on the pre-
synaptic plasma membrane (Humeau et al., 2000; for review
see Teng et al., 2001). In this study, we used clostridium neu-
rotoxins as an experimental tool, to trigger synaptic damage in
central nervous system neurons. BoNT/C triggered two spa-
tially and temporally distinct programs, which mediate neurite
degeneration and apoptosis. In CGCs, BoNT/C caused an
early disassembly of the neuronal network characterized by
progressive vesiculation and fragmentation (Fig. 4, A and B).
This is in agreement with the synaptic terminal swelling and
the neurite network vesiculation induced by BoNT/C in corti-
cal, hippocampal, and spinal cord neurons (Osen-Sand et al.,
1996; Williamson and Neale, 1998). The degeneration of the
projections was independent of the loss of neurotransmitter re-
lease (Fig. 3), was insensitive to trophic stimulation (Fig. 4 F),
and did not require protein synthesis. However, it was an ac-
tive process as shown by the ability of the fragmented pro-
cesses to retain plasma membrane integrity (Figs. 4 B and 6 B)
and by the presence of functional mitochondria along the neu-
rites (Fig. 6 B). On the contrary, the late demise of the cell
body was accompanied by the loss of mitochondrial mem-
brane potential and cytochrome 
 
c
 
 release, before the appear-
ance of any nuclear change (Figs. 2 A and 6 A). Furthermore,
although caspases contributed to the late apoptotic demise of
the cell body (Fig. 2), caspase-independent mechanisms medi-
ated the initial neurodegenerative events (Fig. 4 C). Caspase-
independent axonal degeneration associated with caspase-
dependent apoptosis of the cell body has been described in
Wallerian degeneration of optic and sciatic nerve explants and
in localized axonal degeneration induced by local neurotrophin
deprivation in dorsal root ganglia (Finn et al., 2000). How-
ever, at difference with the predictions of these models, small
amounts of processed caspase-3 were detected along the neu-
ronal projections of BoNT/C-treated CGCs (Fig. 4 C), either
reflecting an undefined housekeeping function of caspase-3
(Campbell and Holt, 2003; for review see Perfettini and Kroe-
mer, 2003) or, reflecting a more effective antiapoptotic ma-
chinery that operates in the neuronal projections (Potts et al.,
2003). The lack of any protective effect of caspase inhibitors
on neurite degeneration (Fig. 4 A) suggests that caspase-3, al-
though processed, is not active or relevant in dismantling
CGN projections.
Neurodegeneration induced by BoNT/C in central neu-
rons resembled axotomy in many of its features (e.g., role of
caspases, cytoskeletal disarray, and phosphatidylserine expo-
sure). However, we tested whether BoNT/C-induced neurode-
generation was attenuated or prevented in the Wallerian degen-
eration slow (
 
Wld
 
s
 
) mice, spontaneous mutants in which axonal
degeneration is greatly delayed, and found no protective effects
(unpublished data). We also tested whether the ubiquitin–pro-
teasome system was required in BoNT/C-triggered neurite de-
generation as it is in the early stages of Wallerian degeneration
(Zhai et al., 2003) or in axonal pruning (Watts et al., 2003). In
our model, inhibition of the ubiquitin–proteasome system did
not affect the degenerative events. Axodendritic fragmentation
within the first 24 h was not prevented by short exposure to
agents that block the proteasome system, nor was apoptosis
(unpublished data). Together, this seems to suggest that also
neurites, as well as the cell body, may activate distinct pro-
grams of self-destructions. 
Although it is now accepted that cell death may involve
distinct molecular mechanisms and take many manifestations
different from classical apoptosis (Leist and Jaattela, 2001), the
possibility of different death programs has seldom been exam-
ined for neurites, which play such an important role for the on-
set and manifestation of several pathologies. Neurodegenera-
tion induced by BoNT/C in CGCs resembled several features
also observed in neurodegenerative disease. A massive damage
of the cytoskeleton underlay neurite disassembly. Both compo-
nents of the cytoskeleton—microfilaments and microtubules—
were affected. Whereas actin changes mainly consisted of a
progressive, general loss, tubulin alterations were characterized
by the appearance of typical rings along the neurites (Fig. 5, A
and B). Similar cytoskeletal abnormalities have been observed
in the early stage of Alzheimer’s disease (Dickson et al., 1999)
as well as in the aging brain (Vickers et al., 1996). In both
cases, dystrophic neurites, which associated with 
 
 
 
-amyloid
plaque, showed bulb- and ringlike structures. These consisted
mainly of neurofilaments, but also consisted of hyperphos-
phorylated tau proteins in the late stages of the disease. In our
system, abnormal tau phosphorylation at the serine 202/205
residues was detected by AT-8–like antibodies during the early
degeneration of neurite (Fig. 5 C). This was associated with a
redistribution of tau along the neurites (Fig. 5 D). 
Although we do not have firm evidence that the cyto-
skeletal disassembly and the tau alterations are the causes of
the cell body apoptosis, there is ample evidence that activation
and mislocalization of Cdk-5 and hyperphosphorylated tau can
lead to apoptosis in other systems (Cheung and Ip, 2004). Be-
cause Cdk-5 inhibitors did not modify tau phosphorylation
in BoNT/C-treated cultures (unpublished data), abnormal tau
phosphorylation via Cdk-5 was not an essential requirement
for apoptosis in this system. However, our data do not exclude
that tau redistribution can play a fundamental role in both the
neurite loss and the onset of apoptosis triggered by BoNT/C.
An aberrant behavior of microtubules and microtubule-associ-
ated proteins can cause disturbances in axonal transport and
impair axonal mitochondrial distribution in the early stages of
Alzheimer’s disease (Ebneth et al., 1998; Mandelkow and
Mandelkow, 1998; Mandelkow et al., 2003). Clearly, our re-
sults with the kinase inhibitors eliminate the possibility that
Cdk-5 or other upstream kinases are involved in the neurite
loss. The selective effect of kinase inhibitors on cell body
apoptosis places Cdk-5 and MAPK upstream of the demise of
the cell body, but downstream of the initial neurodegenerative
events after synaptic damage. 
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Interestingly, all the degenerative effects induced by
BoNT/C were neurospecific, and the population of contami-
nant glial cells present in the culture was not affected. Simi-
larly, BoNT/C did not induce any degenerative or hypertrophic
effect in glial cultures (unpublished data). However, morpho-
logical changes indicative of a state of activation were detected
in the glial cells present in BoNT/C-treated CGC cultures (un-
published data). A common feature of several neurodegenera-
tive diseases is the abundance of reactive astrocytes and
activated microglia in proximity to degenerating neurons. As-
trocytes have been reported to accumulate and surround the
area of amyloid deposition and undergo hypertrophy with the
progression of neurite dystrophy (Mrak et al., 1996). This con-
dition of reactive gliosis seems to be mimicked in BoNT/C-
induced neurodegeneration, and therefore makes this model a
valuable in vitro system for studying the interactions between
injured neurons and glial cells. Moreover, glia seem to partici-
pate in the dismantling of degenerating neurites (Fig. 8 A and
Videos 2 and 3), which exposed recognition molecules as phos-
phatidylserine, well before any sign of apoptosis was detected
in neuronal somata (Fig. 8 B). The temporal and spatial segre-
gation of the degenerative process, including the recognition
and scavenging of dying neurites, may reflect a stereotyped re-
sponse of neurons to injury, which may be relevant to the pro-
gression of slow degenerative diseases and aging. Because
BoNT/C selectively cleaves synaptic proteins (Humeau et al.,
2000; Schiavo et al., 2000), the finding that widespread disrup-
tion of synaptic architecture/function causes neurodegeneration
supports the argument that prolonged synaptic destabilization
may be sufficient to trigger neurodegenerative disease. Strik-
ingly, the effects of BoNT/C on central neurons recapitulate
several of the most relevant features found in human neurode-
generative disorders and in their animal models. Synaptic dam-
age, cytoskeletal modifications, mitochondrial alterations, and
apoptosis are featured in conditions such as Alzheimer’s and
Huntington’s diseases, although the contribution of each of
these processes to neurodegeneration and to disease manifesta-
tion remains unknown. In line with other toxin-related model
systems that have played important roles in understanding neu-
rodegenerative processes, the model described here opens the
door to future exploration of the relationship between synaptic
dysfunction, axonal damage and apoptosis in the CNS.
 
Materials and methods
 
Chemicals
 
Unless otherwise stated, all reagents were obtained from Sigma-Aldrich.
BoNT/C and BoNT/A were initially provided by C. Montecucco (Univer-
sity of Padua, Padua, Italy)
 
, and 
 
were later obtained from Calbiochem.
Caspase inhibitors zVAD-fmk, Ac-YVAD-chloromethylketone, and zD-cbk
were obtained from Bachem. The caspase-2 inhibitor z-VD(OMe)VAD
(OMe)-fmk was purchased from MP Biomedicals. The GSK-3 inhibitor was
synthesized at H. Lundbeck A/S according to standard protocols. SYTOX,
H-33342, calcein-AM, and TMRE were obtained from Molecular Probes.
The caspase substrate, DEVD-aminotrifluoromethylcoumarine (afc) was ob-
tained from Biomol. Solvents and inorganic salts were purchased from
Merck or Riedel-de Haen. 
 
Cell culture
 
Murine CGCs were isolated as described previously (Leist et al., 1997a).
Dissociated neurons were plated on 100 
 
 
 
g/ml (250 
 
 
 
g/ml for glass sur-
faces) poly-
 
L
 
-lysine (molecular mass 
 
 
 
 300 kD)–coated dishes at a density
of 
 
 
 
0.25 
 
 
 
 10
 
6
 
 cells/cm
 
2
 
 (800,000 cells/ml; 500 
 
 l/well, 24-well
plate) and cultured in Eagle’s basal medium (GIBCO BRL) supplemented
with 10% heat-inactivated FCS, 20 mM KCl, 2 mM L-glutamine, penicillin–
streptomycin, and 10  M cytosine arabinoside (added 48 h after plat-
ing). Neurons were used without further medium changes after 6–7 d in
vitro (DIV). The frequency of glial fibrillary acid protein-positive cells was
 5%. The cultures were exposed to BoNT/C in their original medium.
Stock solutions of clostridial neurotoxins were prepared in 150 mM NaCl,
10 mM Hepes, pH 7.4, containing 0.1% BSA.
For time-resolved imaging, cells were grown on ultrathin Lab-Tek
chamber slides (Nunc) and exposed to 20 or 30 ng/ml BoNT/C at 6 DIV.
5 h after treatment, cells were loaded with either with 20 nM TMRE or
with Alexa 633–conjugated annexin V (1:100) and 1  M calcein-AM in
the presence of 2  M MK801 and 10 mM Hepes.
Viability assays
Apoptosis was quantified by staining neuronal cultures with 1  g/ml H-
33342 (membrane permeant, blue fluorescent chromatin stain) as de-
scribed previously (Leist et al., 1997a). Apoptotic cells were characterized
by scoring typically condensed nuclei. About 600–1,000 cells were
counted in nine different fields in more than three different culture wells,
and experiments were repeated in at least three different preparations.
Mitochondrial function and integrity was assessed by the fluorescent, mito-
chondrial membrane potential (  )–sensitive indicator TMRE (20 nM;  ex  
568 nm and  em   590 nm).
HMM DNA fragmentation was quantified as described previously
(Ankarcrona et al., 1995) by field inversion gel electrophoresis. About
1.3   10
6 cells (corresponding to two wells of a 12-well plate) were em-
bedded into 40- l agarose blocks.  -DNA concatemers (n   50 kbp)
were used as molecular mass markers.
Oligonucleosomal DNA fragmentation (DNA laddering) was ana-
lyzed by conventional agarose gel electrophoresis (Wyllie, 1980; Thorn-
berry, 1994). Gels (10% agarose) were stained with SyBRO green and
photographed. DNA ladder (123-4; 182 bp) of the rat prolactin gene
was used as a molecular mass marker.
Enzymatic assays
Caspase-3–like activity (measured by DEVD-afc cleavage) was assayed
essentially as described previously (Thornberry, 1994; Leist et al., 1997b).
CGCs were lysed in 25 mM Hepes, 5 mM MgCl2, 1 mM EGTA, 0.5% Tri-
ton X-100, 1  g/ml leupeptin, 1  g/ml pepstatin, 1  g/ml aprotinin, and
1 mM PEFA block, pH 7.5. The fluorimetric assay was performed in micro-
titer plates with a substrate concentration of 40  M and a total protein
amount of 5  g. DEVD-afc cleavage was followed in the reaction buffer
(50 mM Hepes, 10 mM DTT, 1% sucrose, and 0.1% CHAPS) over a pe-
riod of 30 min at 37 C ( ex   390 nm and  em   505 nm). Absolute activ-
ity was calibrated with afc standard solutions (0–2.5  M). Triple measure-
ments were performed for each sample.
Western blot analysis
CGCs were lysed in RIPA buffer (150 mM NaCl, 50 mM Tris, 1% NP-40,
0.25% sodium deoxycholate, and 1 mM EGTA) supplemented with pro-
tease inhibitors (1 mM PMSF, 1 mM benzamidine, 1 mM iodoacetate, 1
mM iodoacetamide, 40  M leupeptin, 10  g/ml antipain, and 5  g/ml
pepstatin). For the detection of phosphorylated tau protein, the phosphatase
inhibitor sodium orthovanadate (1 mM) was also added. Protein content
was determined using the bicinchoninic acid method (Bio-Rad Laboratories).
Proteins were separated by SDS-PAGE with 15  g protein/lane
on 12% polyacrylamide gels for syntaxin, 5  g protein/lane on 8%
polyacrylamide gels for fodrin, 50  g protein/lane on 8% polyacryl-
amide gels for tau protein, 100  g protein/lane on 12% polyacryl-
amide gels for processed caspase-3, and then blotted onto nitrocellulose
membranes (Amersham Biosciences) in a semi-dry blotter (Bio-Rad Labo-
ratories). Blots were blocked in TNT (50 mM Tris, pH 8.0, 150 mM
NaCl, and 0.05% Tween 20) containing 5% dried milk and incubated
with either antisyntaxin mAb (1:10,000; clone 78.3; Synaptic Systems),
anti–SNAP-25 mAb (1:10,000; clone 71.2; Synaptic Systems), antifodrin
mAb (1:500; clone 1622; Chemicon International), anticleaved cas-
pase-3 polyclonal antibody (1:1,000; Asp175; Cell Signaling), or anti-
tau protein polyclonal antibodies (K9JA, 1:5, 000; 11b 1:2,000). Tau
antibodies were a gift from Eva-Maria and Eckhard Mandelkow (Max-
Planck Institute, Hamburg, Germany). Specifically stained bands were
detected by chemiluminescence (ECL; Amersham Biosciences) using a
polyclonal IgG horseradish peroxidase–coupled secondary antibody
(1:1,000; BD Biosciences).JCB • VOLUME 168 • NUMBER 4 • 2005 616
Determination of L-[G-
3H]-glutamate release
Cells were exposed to BoNT/C as indicated in Fig. 3. To avoid excitotox-
icity via the NMDA receptor, 2  M MK801 (RBI; Biotrend Chemikalien
GmbH) and 2 mM MgCl2 were added 30 min before the removal of the
medium and were present throughout the loading, washing, and releasing
steps of the assay. Neurons were loaded with 37 kBq/ml L-[G-
3H]gluta-
mine (Amersham Biosciences; spec. act., 1.96 TBq/mmol) in CSS25 (CSS
with 25 mM KCl) for 30 min at 37 C and washed three times in the same
buffer. During this incubation period, the labeled L-glutamine is taken up
by the neurons, converted into glutamate by mitochondrial glutaminase
and packed into synaptic vesicles (McMahon and Nicholls, 1990). After
30 min of equilibration in CSS5 (CSS with 5 mM KCl) at 37 C, L-glu-
tamate release was measured after stimulation with 55 mM KCl or 10  M
veratridine for 4 min. Supernatants were removed and counted for tritium.
Cells were then lysed in 0.3% Triton X-100/PBS for 30 min, and the resid-
ual accumulated L-[G-
3H]glutamate was measured. Values were calculated
as a percentage of the total cellular tritium content, the basal release was
subtracted, and the control release was set to 100%.
Immunofluorescence
CGCs were grown on glass coverslips, fixed after the experiment with 4%
PFA and permeabilized with 0.1% Triton X-100 in PBS. For the detec-
tion of active caspase, a rabbit polyclonal antibody (cleaved caspase-3,
Asp175; Cell Signaling) was used. The specificity of the staining was
tested by incubating the antibody with the p20/p17 fragment of cas-
pase-3 in the presence of zVAD-fmk. To monitor cytoskeleton alterations,
cells were incubated with the neurospecific mouse mAb anti– III-tubulin
(Promega). As a secondary antibody, we used an Alexa ( ex   488 nm
and  em   512 nm)-coupled anti–mouse IgG (1:600, Molecular Probes).
Tau protein was detected by using the mouse monoclonal AT8 antibody
(Innogenetics). Actin was detected by Alexa 568–conjugated phalloidin
( ex   568 nm and  em   603 nm). Cytochrome c and mtHSP-70 were de-
tected via mouse mAbs (Cyt c: clone 6H2.B4 [PharMingen]; mtHSP-70:
clone JG1 [Abcam]). For the double staining, antibodies for cytochrome c
and HSP70 were labeled with Alexa Fluor 488 ( ex   495 nm and  em  
519 nm) and 546 ( ex   556 nm and  ex   573 nm), respectively, by us-
ing the Zenon mouse IgG labeling kit (Molecular Probes). Cultures were
counterstained with 0.5  g/ml H-33342.
Confocal microscopy
Confocal microscopy images were acquired using a laser scanning micro-
scope (model LSM 510 Combi; Carl Zeiss MicroImaging, Inc.) equipped with
visible and infrared Ti-Sa pulsed laser (Tsunami/Millenia Spectra-Physics).
If not otherwise stated, all images were collected using a 40  oil 1.3 NA
apochromat objective (Carl Zeiss MicroImaging, Inc.). Postacquisition pro-
cessing was performed with Adobe Photoshop and Adobe Illustrator.
Time-resolved imaging
Images for time-resolved experiments were collected using either confocal
(Figs. 6 A and 8 B, Video 1, and Fig. S1) or conventional (Fig. 8 A and
Videos 2 and 3) microscopy. Cells were thermostated using a heated
stage (Carl Zeiss MicroImaging, Inc.), and the temperature was kept con-
stantly at 34 C ( 1.5 C). Additionally, pH was maintained by perfusing
cell with 5% CO2 using a CO2 controller (MicroImaging, Inc.). Images
were collected with a time interval of 15 min. Settings were optimized in
order to reduce photobleaching to a minimum, and laser stability was con-
trolled using an internal photodiode monitor as reference.
Colocalization
Quantitative colocalization was performed using ImarisColoc software (Bit-
plane AG). Image stacks were collected using a laser scanning micro-
scope. Image stacks were then loaded in Imaris, and quantitative colocal-
ization was determined. Threshold for colocalization was automatically set
using the automatic threshold function of the software. Intensity pairs of the
two channels that exhibit no correlation (Pearson’s correlation coefficient  
0) were excluded from the analysis. Once the first step was obtained, then
the software calculated the percentage of voxels that colocalize.
Scanning electron microscopy
CGCs that were grown on glass coverslips were immersed in Karnovsky’s fix-
ative and ferrocyanide-reduced osmium tetroxide before being treated with
5% uranyl acetate and dehydrated with a series of alcohols. They were trans-
ferred to hexamethyldisilazane and air dried before being sputter coated
with a 15-nm layer of gold and examined in an electron microscope (model
100CXII; JEOL) equipped with an ASID-4D scanning unit (JEOL). Postacquisi-
tion processing was performed with Adobe Photoshop and Adobe Illustrator.
Statistics
Experiments to determine cell viability or caspase activity were run as trip-
licates and repeated in three to eight cell preparations. Statistical signifi-
cance was calculated on the original datasets using the t test. All Western
blots and immunostainings were performed with samples from at least
three independent cell preparations.
Online supplemental material
All videos were acquired as described in the Time-resolved imaging sec-
tion, processed using QuickTimePro (Video 1) or Adobe Premiere Pro
(Videos 2 and 3) and saved as Quicktime movies.
Fig. S1 shows the distribution of phosphatidylserine along neuronal
projections in a three-dimensional reconstruction.Video 1 shows a dynamic
recording of the mitochondrial membrane potential clustering around the
cell nucleus of neurons exposed to 25 ng/ml BoNT/C for 33 h and almost
completely deprived of connections. Video 2 shows the clearance of de-
generating neurites by a glial cell. Video 3 shows the clearance of apop-
totic neuronal bodies during the late phase of neurodegeneration. Online
supplemental material is available http://www.jcb.org/cgi/content/full/
jcb.200406126/DC1.
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